MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells

N Hondo, M Kitazawa, M Koyama, S Nakamura… - Cancer Letters, 2023 - Elsevier
… a combination therapy targeting feedback reactivation would … that feedback reactivation of
the MAPK pathway and EGFR … in CRC, and that the combination of MEK inhibitors and anti-…

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

R Sigaud, L Rösch, C Gatzweiler, J Benzel… - Neuro …, 2023 - academic.oup.com
… the MAPK pathway on the level of RAF, 19 potentially enabling MAPK pathway reactivation
after … We investigated potential antitumoral effects of ulixertinib in combination with MEK

Resistance to MAPK inhibitors in melanoma involves activation of the IGF1R–MEK5–Erk5 pathway

L Benito-Jardón, M Díaz-Martínez, N Arellano-Sánchez… - Cancer research, 2019 - AACR
Combined treatment of metastatic melanoma with BRAF and MEK inhibitors has improved
… converge in the reactivation of the BRAF–MEK–ERK pathway usually following NRAS …

Abstract B076: Uncoupling of the cell cycle pathway from the MAPK pathway in BRAF/MEK inhibitor resistant melanoma

KW Nassar, J Hintzsche, S Bagby… - Molecular Cancer …, 2019 - AACR
reactivation of MAPK pathway, via NRAS mutations, and activation of the cell cycle pathway,
… be sensitive to the combination of inhibiting the MAPK and cell cycle pathway. Both BRAFi/…

Extracellular signal-regulated kinase (ERK) inhibitors in oncology clinical trials

HM Chin, DK Lai, GS Falchook - … of Immunotherapy and …, 2019 - meridian.allenpress.com
… patients after about year due to reactivation of the MAPK pathway. [8] One way, the MAPK …
(2) feedback reactivation of the MAPK pathway. [5,11] The ERK/MEK inhibitor combination has …

Dissecting mechanisms of melanoma resistance to BRAF and MEK inhibitors revealed genetic and non-genetic patient-and drug-specific alterations and remarkable …

ML Hartman, M Sztiller-Sikorska, A Gajos-Michniewicz… - Cells, 2020 - mdpi.com
pathway is frequently associated with the reactivation of this … to BRAF inhibition or combined
BRAF/MEK inhibition [59,60], … preceding development of resistance to MEK inhibition [61]. …

Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma

J Rožanc, T Sakellaropoulos, A Antoranz… - Cell Death & …, 2019 - nature.com
… that combining MEK inhibition … pathways that alone or in combination cause or regulate
intrinsic and adaptive resistance. This includes, for example, reactivation of the MAPK pathway

The combination of trametinib, a MEK inhibitor, and temsirolimus, an mTOR inhibitor, Radiosensitizes lung cancer cells

SY Kim, EH Jeong, TG Lee, HR Kim… - Anticancer …, 2021 - ar.iiarjournals.org
… inhibitor (PD98059) and PI3K inhibitor (PI-103) blocked Akt reactivation, impaired double-…
and MEK/ERK pathways. If both pathways are not blocked, the inhibition of one pathway can …

Targeting RAS mutant colorectal cancer with dual inhibition of MEK and CDK4/6

AV Sorokin, P Kanikarla Marie, L Bitner, M Syed… - Cancer Research, 2022 - AACR
… It was previously shown that the combination of MEK and … previously reported that combining
a MEK inhibitor (trametinib) … signaling networks leading to reactivation of the pathway, with …

Ripretinib and MEK inhibitors synergize to induce apoptosis in preclinical models of GIST and systemic mastocytosis

A Gupta, J Singh, A García-Valverde, C Serrano… - Molecular Cancer …, 2021 - AACR
… Here we show that ripretinib treatment in combination with MEK … Our results show that
the combination of KIT and MEKpathway mutations that result in reactivation of the MAPK …